Suppr超能文献

胰高血糖素在健康和疾病中的代谢作用。

Glucagon's Metabolic Action in Health and Disease.

机构信息

Institute for Diabetes and Cancer, Helmholtz Center Munich, Neuherberg, Germany.

German Center for Diabetes Research (DZD), Neuherberg, Germany.

出版信息

Compr Physiol. 2021 Apr 1;11(2):1759-1783. doi: 10.1002/cphy.c200013.

Abstract

Discovered almost simultaneously with insulin, glucagon is a pleiotropic hormone with metabolic action that goes far beyond its classical role to increase blood glucose. Albeit best known for its ability to directly act on the liver to increase de novo glucose production and to inhibit glycogen breakdown, glucagon lowers body weight by decreasing food intake and by increasing metabolic rate. Glucagon further promotes lipolysis and lipid oxidation and has positive chronotropic and inotropic effects in the heart. Interestingly, recent decades have witnessed a remarkable renaissance of glucagon's biology with the acknowledgment that glucagon has pharmacological value beyond its classical use as rescue medication to treat severe hypoglycemia. In this article, we summarize the multifaceted nature of glucagon with a special focus on its hepatic action and discuss the pharmacological potential of either agonizing or antagonizing the glucagon receptor for health and disease. © 2021 American Physiological Society. Compr Physiol 11:1759-1783, 2021.

摘要

胰高血糖素与胰岛素几乎同时被发现,是一种具有代谢作用的多功能激素,其作用远远超出了其增加血糖的经典作用。尽管胰高血糖素最出名的是其直接作用于肝脏以增加葡萄糖的从头合成并抑制糖原分解的能力,但它通过减少食物摄入和增加代谢率来降低体重。胰高血糖素进一步促进脂肪分解和脂质氧化,并在心脏中具有正性变时性和变力性作用。有趣的是,近几十年来,随着人们认识到胰高血糖素除了作为治疗严重低血糖的抢救药物的经典用途之外,还具有药理学价值,胰高血糖素的生物学特性出现了显著的复兴。本文总结了胰高血糖素的多方面特性,特别关注其肝脏作用,并讨论了激动或拮抗胰高血糖素受体在健康和疾病方面的药理学潜力。© 2021 美国生理学会。《综合生理学》11:1759-1783, 2021。

相似文献

1
4
Hepatic glucagon action: beyond glucose mobilization.肝胰高血糖素作用:超越葡萄糖动员。
Physiol Rev. 2024 Jul 1;104(3):1021-1060. doi: 10.1152/physrev.00028.2023. Epub 2024 Feb 1.
6
Clinical Pharmacology of Glucagon.胰高血糖素的临床药理学。
Clin Pharmacol Ther. 2024 Oct;116(4):976-979. doi: 10.1002/cpt.3340. Epub 2024 Jun 7.

引用本文的文献

2
Advances in magnetic resonance spectroscopy for metabolic disorders.用于代谢紊乱的磁共振波谱学进展。
Front Endocrinol (Lausanne). 2025 Jul 18;16:1578333. doi: 10.3389/fendo.2025.1578333. eCollection 2025.
9
Characterization of LY3324954 a long-acting glucagon-receptor agonist.长效胰高血糖素受体激动剂LY3324954的特性
Mol Metab. 2025 Jan;91:102073. doi: 10.1016/j.molmet.2024.102073. Epub 2024 Nov 25.

本文引用的文献

1
Alpha cell regulation of beta cell function.α 细胞对 β 细胞功能的调节。
Diabetologia. 2020 Oct;63(10):2064-2075. doi: 10.1007/s00125-020-05196-3. Epub 2020 Sep 7.
6
Glucagon-like peptide 1 (GLP-1).胰高血糖素样肽 1(GLP-1)。
Mol Metab. 2019 Dec;30:72-130. doi: 10.1016/j.molmet.2019.09.010. Epub 2019 Sep 30.
8
Glucagon Regulation of Energy Expenditure.胰高血糖素对能量消耗的调节作用。
Int J Mol Sci. 2019 Oct 30;20(21):5407. doi: 10.3390/ijms20215407.
10
YIPF6 controls sorting of FGF21 into COPII vesicles and promotes obesity.YIPF6 控制 FGF21 分拣到 COPII 囊泡中,并促进肥胖。
Proc Natl Acad Sci U S A. 2019 Jul 23;116(30):15184-15193. doi: 10.1073/pnas.1904360116. Epub 2019 Jul 9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验